The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Matrix synthesis and degradation in human intervertebral disc degeneration
Abstract
Degeneration of the intervertebral disc has been implicated in chronic low back pain. Type II collagen and proteoglycan (predominantly aggrecan) content is crucial to proper disc function, particularly in the nucleus pulposus. In degeneration, synthesis of matrix molecules changes, leading to an increase in the synthesis of collagens type I and III and a decreased production of aggrecan. Linked to this is an increased expression of matrix-degrading molecules including MMPs (matrix metalloproteinases) and the aggrecanases, ADAMTS (a disintegrin and metalloprotease with thrombospondin motifs) 1, 4, 5, 9 and 15, all of which are produced by native disc cells. Importantly, we have found that there is a net increase in these molecules, over their natural inhibitors [TIMP-1 (tissue inhibitor of metalloproteinases-1), 2 and 3], suggesting a deregulation of the normal homoeostatic mechanism. Growth factors and cytokines [particularly TNFα (tumour necrosis factor α) and IL-1 (interleukin 1)] have been implicated in the regulation of this catabolic process. Our work has shown that in degenerate discs there is an increase in IL-1, but no corresponding increase in the inhibitor IL-1 receptor antagonist. Furthermore, treatment of human disc cells with IL-1 leads to a decrease in matrix gene expression and increased MMP and ADAMTS expression. Inhibition of IL-1 would therefore be an important therapeutic target for preventing/reversing disc degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deyo, R. A., & Weinstein, J. N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440508 · Cited by 1,675
The economic burden of back pain in the UK
Maniadakis, N., & Gray, A. (2000) · Pain · doi:10.1016/s0304-3959(99)00187-6 · Cited by 1,510
Nerve ingrowth into diseased intervertebral disc in chronic back pain
Freemont, A., Peacock, T., Goupille, P., Hoyland, J., O'Brien, J., & Jayson, M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02135-1 · Cited by 989
Self-citationThe role of interleukin-1 in the pathogenesis of human Intervertebral disc degeneration
Le Maitre, C. L., Freemont, A. J., & Hoyland, J. A. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1732 · Cited by 806
Self-citationMaroudas, A., Stockwell, R. A., NACHEMSON, A. K., & Urban, J. (1975) · PubMed Central · Cited by 567
Aggrecanases and cartilage matrix degradation.
Nagase, H., & Kashiwagi, M. (2003) · Arthritis Research · doi:10.1186/ar630 · Cited by 514
Matrix Metalloproteinases And Aggrecanase: Their Role in Disorders of the Human Intervertebral Disc
Roberts, S., Caterson, B., Menage, J., Evans, E. H., Jaffray, D. C., & Eisenstein, S. M. (2000) · Spine · doi:10.1097/00007632-200012010-00007 · Cited by 500
Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc
Le Maitre, C. L., Freemont, A. J., & Hoyland, J. A. (2004) · The Journal of Pathology · doi:10.1002/path.1608 · Cited by 443
Self-citationGruber, H. E., & Hanley, E. N. (1998) · Spine · doi:10.1097/00007632-199804010-00001 · Cited by 415
Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs
Sive, J. I. (2002) · Molecular Pathology · doi:10.1136/mp.55.2.91 · Cited by 367
Cited by
The role of IL-1β and TNF-α in intervertebral disc degeneration
Wang, Y., Che, M., Xin, J., Zheng, Z., Li, J., & Zhang, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110660 · Cited by 627
Richardson, S. M., Kalamegam, G., Pushparaj, P. N., Matta, C., Memic, A., Khademhosseini, A., Mobasheri, R., Poletti, F. L., Hoyland, J. A., & Mobasheri, A. (2016) · Methods · doi:10.1016/j.ymeth.2015.09.015 · Cited by 504
Self-citationThe cellular pathobiology of the degenerate intervertebral disc and discogenic back pain
Freemont, A. J. (2008) · Rheumatology · doi:10.1093/rheumatology/ken396 · Cited by 485
Self-citationInflammation in intervertebral disc degeneration and regeneration
Molinos, M., Almeida, C. R., Caldeira, J., Cunha, C., Gonçalves, R. M., & Barbosa, M. A. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.1191 · Cited by 454
Vo, N. V., Hartman, R. A., Yurube, T., Jacobs, L. J., Sowa, G. A., & Kang, J. D. (2013) · The Spine Journal · doi:10.1016/j.spinee.2012.02.027 · Cited by 433
Degeneration and regeneration of the intervertebral disc: lessons from development
Smith, L. J., Nerurkar, N. L., Choi, K.-S., Harfe, B. D., & Elliott, D. M. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006403 · Cited by 397
Diversity of intervertebral disc cells: phenotype and function
Pattappa, G., Li, Z., Peroglio, M., Wismer, N., Alini, M., & Grad, S. (2012) · Journal of Anatomy · doi:10.1111/j.1469-7580.2012.01521.x · Cited by 331
Advancing the cellular and molecular therapy for intervertebral disc disease
Sakai, D., & Grad, S. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.06.009 · Cited by 312
Cell-based strategies for IVD repair: clinical progress and translational obstacles
Binch, A. L. A., Fitzgerald, J. C., Growney, E. A., & Barry, F. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00568-w · Cited by 296
Xing, H., Zhang, Z., Mao, Q., Wang, C., Zhou, Y., Zhou, X., Ying, L., Xu, H., Hu, S., & Zhang, N. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00991-5 · Cited by 296
Laboratory of Cell Proliferation and Ageing, I. O. B. A. A., Dimozi, A., Demokritos, 1. 1. A., Mavrogonatou, E., Sklirou, A., & Kletsas, D. (2015) · European Cells and Materials · doi:10.22203/ecm.v030a07 · Cited by 273
Risbud, M. V., Schoepflin, Z. R., Mwale, F., Kandel, R. A., Grad, S., Iatridis, J. C., Sakai, D., & Hoyland, J. A. (2015) · Journal of Orthopaedic Research · doi:10.1002/jor.22789 · Cited by 268
Self-citationDaly, C., Ghosh, P., Jenkin, G., Oehme, D., & Goldschlager, T. (2016) · BioMed Research International · doi:10.1155/2016/5952165 · Cited by 255
Metadata
- Authors
- Le Maitre, C. L., Pockert, A., Buttle, D. J., Freemont, A. J., & Hoyland, J. A.
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2007-07-20
- Volume
- 35
- Issue
- 4
- Pages
- 652-655
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W2166016039
- Cited by
- 515
- References
- 28
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.